Begins experimenting with PTX mixed with antibiotic Cipro. Last patients enrolled in PTX study. It becomes clear PTX alone is a failure. February Bianco and Singer leave The Hutch to run company. July Learns that cancer has returned.
Prognosis is death within two years.
CTI files for patent on new drug derived from PTX, called Lisofylline. Austrian and German doctors publish study saying PTX doesn t work. Bensinger decides to stop using the IV form of PTX in his study. January Institutional Review Board orders mention of IV form of PTX deleted from patient-consent forms for Protocol 681. Has informed-consent conference with Hutch doctor, a day after the IRB action.